What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Pathology, Carcinoma, Serous fluid, Internal medicine and Adenocarcinoma.
His study in Pathology is interdisciplinary in nature, drawing from both Cancer and Microsatellite instability.
His Carcinoma research is multidisciplinary, incorporating perspectives in Uterine serous carcinoma, Radiology, Retrospective cohort study and Tissue microarray.
The study incorporates disciplines such as Serous carcinoma, Clear cell carcinoma, Clear cell, Ovarian carcinoma and Cystadenocarcinoma in addition to Serous fluid.
He has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study.
Odds ratio, Case-control study and Survival analysis is closely connected to Not Otherwise Specified in his research, which is encompassed under the umbrella topic of Adenocarcinoma.
His most cited work include:
- Integrated genomic characterization of endometrial carcinoma (2370 citations)
- COX-2 is expressed in human pulmonary, colonic, and mammary tumors. (763 citations)
- Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. (660 citations)
What are the main themes of his work throughout his whole career to date?
Robert A. Soslow mainly focuses on Pathology, Carcinoma, Internal medicine, Oncology and Serous fluid.
His study focuses on the intersection of Pathology and fields such as Adenocarcinoma with connections in the field of Cervix.
As part of one scientific family, Robert A. Soslow deals mainly with the area of Carcinoma, narrowing it down to issues related to the Gynecology, and often Hysterectomy.
His Oncology study integrates concerns from other disciplines, such as Survival rate, Disease and Microsatellite instability.
The various areas that Robert A. Soslow examines in his Serous fluid study include Ovarian carcinoma, Serous Tubal Intraepithelial Carcinoma, Cystadenocarcinoma and Clear cell carcinoma.
In his study, which falls under the umbrella issue of Immunohistochemistry, KRAS is strongly linked to Cancer research.
He most often published in these fields:
- Pathology (50.60%)
- Carcinoma (31.67%)
- Internal medicine (31.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Pathology (50.60%)
- Internal medicine (31.08%)
- Oncology (24.50%)
In recent papers he was focusing on the following fields of study:
Pathology, Internal medicine, Oncology, Carcinoma and Cancer research are his primary areas of study.
Robert A. Soslow interconnects Serous carcinoma and PAX8 in the investigation of issues within Pathology.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Ovarian cancer and Tumor size, as a part of the same area of interest.
His research investigates the connection between Oncology and topics such as Microsatellite instability that intersect with problems in Lynch syndrome.
His research in Carcinoma intersects with topics in Adenosquamous carcinoma, General surgery and Uterus.
His Cancer research research focuses on subjects like Ovary, which are linked to Endometrium.
Between 2018 and 2021, his most popular works were:
- Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility. (79 citations)
- Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. (59 citations)
- High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations (55 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Pathology, Oncology, Internal medicine, Carcinoma and Endometrial cancer.
His research integrates issues of Gene rearrangement and Myometrium in his study of Pathology.
His research integrates issues of Lymphovascular invasion, Serous ovarian cancer, Lymph node, Adjuvant therapy and Adenocarcinoma in his study of Oncology.
He interconnects Serous carcinoma, PAX8, Tp53 mutation, Adenosquamous carcinoma and Endometrial Carcinomas in the investigation of issues within Carcinoma.
His Endometrial cancer research incorporates elements of Stage, Biopsy, Clear cell carcinoma and Cohort.
Within one scientific family, he focuses on topics pertaining to YWHAE under Immunohistochemistry, and may sometimes address concerns connected to Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
